Evidence map›Paper›PMID 22357553›Full record

ArticleMolecular & cellular proteomics : MCP2012

Nucleocytoplasmic transport: a role for nonspecific competition in karyopherin-nucleoporin interactions.

Jaclyn Tetenbaum-Novatt, Loren E Hough, Roxana Mironska, Anna Sophia McKenney, Michael P Rout

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 66 citations in OpenAlex.

  1. HIV-1 capsid interactions with Nuclear Pore Complex components support nuclear entry via affinity gradient.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Structure, function and assembly of nuclear pore complexes.Nature reviews. Molecular cell biology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. The Great Escape: mRNA Export through the Nuclear Pore Complex.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jaclyn Tetenbaum-NovattThe Laboratory of Cellular and Structural Biology, The Rockefeller University, New York, New York 10065, USA.
Loren E Hough
Roxana Mironska
Anna Sophia McKenney
Michael P Rout
Rockefeller University · US

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
NEW TOOLS FOR EXPLORING THE DYNAMIC INTERACTOME(RMI)U54RR022220 · NCRR · ROCKEFELLER UNIVERSITY · PI ROUT, MICHAEL P · 2005 to 2011
$19.3M
Virtual Gating Machines for Protein PurificationR01GM071329 · NIGMS · ROCKEFELLER UNIVERSITY · PI ROUT, MICHAEL P · 2004 to 2013
$4.6M
DISSECTING THE MOLECULAR MACHINERY OF NUCLEAR TRANSPORTR01GM062427 · NIGMS · ROCKEFELLER UNIVERSITY · PI ROUT, MICHAEL P · 2001 to 2010
$2.7M
Direct visualization of the FG nups, the selective gating for nuclear transportF32GM087854 · NIGMS · ROCKEFELLER UNIVERSITY · PI HOUGH, LOREN E · 2009 to 2010
$61k
Howard Hughes Medical InstituteNCRR NIH HHS U54 RR022220NIGMS NIH HHS F32 GM087854NIGMS NIH HHS R01 GM062427NIGMS NIH HHS R01 GM071329NIGMS NIH HHS R01 GM62427NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

Nucleocytoplasmic transport occurs through the nuclear pore complex (NPC), which in yeast is a ~50 MDa complex consisting of ~30 different proteins. Small molecules can freely exchange through the NPC, but macromolecules larger than ~40 kDa must be aided across by transport factors, most of which belong to a related family of proteins termed karyopherins (Kaps). These transport factors bind to the disordered phenylalanine-glycine (FG) repeat domains in a family of NPC proteins termed FG nups, and this specific binding allows the transport factors to cross the NPC. However, we still know little in terms of the molecular and kinetic details regarding how this binding translates to selective passage of transport factors across the NPC. Here we show that the specific interactions between Kaps and FG nups are strongly modulated by the presence of a cellular milieu whose proteins appear to act as very weak competitors that nevertheless collectively can reduce Kap/FG nup affinities by several orders of magnitude. Without such modulation, the avidities between Kaps and FG nups measured in vitro are too tight to be compatible with the rapid transport kinetics observed in vivo. We modeled the multivalent interactions between the disordered repeat binding sites in the FG nups and multiple cognate binding sites on Kap, showing that they should indeed be sensitive to even weakly binding competitors; the introduction of such competition reduces the availability of these binding sites, dramatically lowering the avidity of their specific interactions and allowing rapid nuclear transport.

Indexed as

Active Transport, Cell NucleusSaccharomyces cerevisiaeAlgorithmsAmino Acid SequenceBacterial Proteinsbeta KaryopherinsBinding, CompetitiveEscherichia coliMembrane Transport ProteinsModels, MolecularNuclear Pore Complex ProteinsProtein BindingReceptors, Cytoplasmic and NuclearRecombinant ProteinsSaccharomyces cerevisiae ProteinsSerum Albumin, BovineBacterial Proteinsbeta KaryopherinsKap123 protein, S cerevisiaeMembrane Transport ProteinsNuclear Pore Complex ProteinsPSE1 protein, S cerevisiaeReceptors, Cytoplasmic and NuclearRecombinant ProteinsSaccharomyces cerevisiae ProteinsSerum Albumin, Bovine

Identifiers

PMID22357553
PMCPMC3418842
OpenAlexW2157408408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.